Your browser doesn't support javascript.
loading
Immunization with a Prefusion SARS-CoV-2 Spike Protein Vaccine (RBMRNA-176) Protects against Viral Challenge in Mice and Nonhuman Primates.
Ma, Qinhai; Li, Runfeng; Guo, Jianmin; Li, Man; Ma, Lin; Dai, Jun; Shi, Yongxia; Dai, Jinlong; Huang, Yuankeng; Dai, Cailing; Pan, Weiqi; Zhong, Huiling; Zhang, Hong; Wen, Jian; Zhao, Haoting; Wu, Linping; Yang, Wei; Zhang, Biliang; Yang, Zifeng.
Afiliación
  • Ma Q; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510000, China.
  • Li R; Guangzhou Laboratory, Guangzhou 510000, China.
  • Guo J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510000, China.
  • Li M; Guangzhou Laboratory, Guangzhou 510000, China.
  • Ma L; Guangdong Provincial Key Laboratory of Drug Non-Clinical Evaluation and Research, Guangdong Lewwin Pharmaceutical Research Institute Co., Ltd., Guangdong Engineering Research Center for Innovative Drug Evaluation and Research, Guangzhou 510000, China.
  • Dai J; Division of Life Science, Center for Cancer Research, and State Key Laboratory for Molecular Neuroscience, Hong Kong University of Science and Technology, Hong Kong, China.
  • Shi Y; Argorna Pharmaceuticals Co., Ltd., Guangzhou 510000, China.
  • Dai J; Guangzhou RiboBio Co., Ltd., Guangzhou 510000, China.
  • Huang Y; Technology Centre, Guangzhou Customs, Guangzhou 510000, China.
  • Dai C; Technology Centre, Guangzhou Customs, Guangzhou 510000, China.
  • Pan W; Guangdong Provincial Key Laboratory of Drug Non-Clinical Evaluation and Research, Guangdong Lewwin Pharmaceutical Research Institute Co., Ltd., Guangdong Engineering Research Center for Innovative Drug Evaluation and Research, Guangzhou 510000, China.
  • Zhong H; Guangdong Provincial Key Laboratory of Drug Non-Clinical Evaluation and Research, Guangdong Lewwin Pharmaceutical Research Institute Co., Ltd., Guangdong Engineering Research Center for Innovative Drug Evaluation and Research, Guangzhou 510000, China.
  • Zhang H; Guangdong Provincial Key Laboratory of Drug Non-Clinical Evaluation and Research, Guangdong Lewwin Pharmaceutical Research Institute Co., Ltd., Guangdong Engineering Research Center for Innovative Drug Evaluation and Research, Guangzhou 510000, China.
  • Wen J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510000, China.
  • Zhao H; Argorna Pharmaceuticals Co., Ltd., Guangzhou 510000, China.
  • Wu L; Argorna Pharmaceuticals Co., Ltd., Guangzhou 510000, China.
  • Yang W; Guangzhou RiboBio Co., Ltd., Guangzhou 510000, China.
  • Zhang B; Guangzhou RiboBio Co., Ltd., Guangzhou 510000, China.
  • Yang Z; State Key Laboratory of Respiratory Disease, Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510000, China.
Vaccines (Basel) ; 10(10)2022 Oct 11.
Article en En | MEDLINE | ID: mdl-36298563
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: China